ADJUVANT CHEMOTHERAPY FOR TREATMENT OF UNRESECTABLE AND METASTATIC ANGIOMATOID MALIGNANT FIBROUS HISTIOCYTOMA

被引：1

作者：

BERNINI, JC

FORT, DW

PRITCHARD, M

ROGERS, BB

WINICK, NJ

机构：

[1] UNIV TEXAS,SW MED CTR,DEPT PEDIAT HEMATOL ONCOL,DALLAS,TX

[2] UNIV TEXAS,SW MED CTR,DEPT RADIOL,DALLAS,TX 75235

[3] UNIV TEXAS,SW MED CTR,DEPT PATHOL,DALLAS,TX

[4] CHILDRENS MED CTR,DALLAS,TX 75235

来源：

CANCER | 1994年 / 74卷 / 03期

关键词：

ANGIOMATOID MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT FIBROUS HISTIOCYTOMA; SARCOMA; CHILDREN;

D O I：

10.1002/1097-0142(19940801)74:3<962::AID-CNCR2820740327>3.0.CO;2-A

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Angiomatoid malignant fibrous histiocytoma (AMFH) is a low grade soft tissue sarcoma usually treated with surgery alone. Only one adult patient has been treated with systemic chemotherapy. The authors report a case of unresectable, metastatic AMFH treated initially with vincristine, doxorubicin, dactinomycin, and cyclophosphamide. A complete response at the metastatic site and a marked reduction in the size of the primary tumor allowed complete surgical excision 7 months after treatment was initiated. The patient remains disease free 19 months after being diagnosed. It was concluded that systemic chemotherapy may be effective in patients with AMFH.

引用

页码：962 / 964

页数：3

共 7 条

[1] ANGIOMATOID MALIGNANT FIBROUS HISTIOCYTOMA - A FOLLOW-UP-STUDY OF 108 CASES WITH EVALUATION OF POSSIBLE HISTOLOGIC PREDICTORS OF OUTCOME [J].